Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

TidsskriftClinical Case Reports
Udgave nummer12
Sider (fra-til)2874-2877
Antal sider4
StatusUdgivet - 2020

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 249860508